Skip to content
Sample Page
Author:
EndoCyclic Therapeutics
Posted Date:
March 23, 2026
EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis
EndoCyclic Therapeutics
March 23, 2026
